Ads
related to: crispr therapeutics news today
Search results
Why CRISPR Therapeutics Stock Crushed the Market Today
Motley Fool· 7 months agoLeading gene therapy company CRISPR Therapeutics (NASDAQ: CRSP) had quite the memorable day on the...
Is CRISPR Therapeutics a Buy in the New Bull Market?
Motley Fool via Yahoo Finance· 4 months agoCRISPR Therapeutics (NASDAQ: CRSP) soared 54% last year as growth stocks rallied and the company itself moved toward an important milestone: the approval...
Why CRISPR Therapeutics Stock Is Jumping Again Today
Motley Fool· 7 months agoShares of CRISPR Therapeutics (NASDAQ: CRSP) were jumping 10.1% higher as of 10:58 a.m. ET on Friday. The solid move followed Thursday's gain of more...
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
Motley Fool· 6 months agoCRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) received great news last week. Its gene-editing therapy, which it has been developing with Vertex Pharmaceuticals,...
Could CRISPR Therapeutics Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 4 months agoRight now marks an exciting moment for CRISPR Therapeutics (NASDAQ: CRSP) and its investors. The...
Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval
GuruFocus.com via Yahoo Finance· 7 months agoThe gene editing sector experienced a significant shakeup as CRISPR Therapeutics (NASDAQ:CRSP) and...
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
Motley Fool· 7 months agoCRISPR Therapeutics (NASDAQ: CRSP) has reached a very exciting point in its story. The biotech...
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?
Motley Fool via Yahoo Finance· 6 months agoIntellia Therapeutics (NASDAQ: NTLA) and CRISPR Therapeutics (NASDAQ: CRSP) have one big thing in...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The...